Hainan Huluwa Pharmaceutical Group Co., Ltd.
SSE:605199.SS
9.59 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 254.293 | 522.69 | 480.369 | 487.681 | 345.877 | 154.089 | 181.464 | 82.592 | 62.184 |
| Short Term Investments
| 18.422 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 254.293 | 522.69 | 480.369 | 487.681 | 345.877 | 154.089 | 181.464 | 82.592 | 62.184 |
| Net Receivables
| 419.545 | 590.134 | 453.678 | 355.415 | 383.943 | 207.919 | 171.992 | 85.448 | 28.901 |
| Inventory
| 446.77 | 265.562 | 213.561 | 213.225 | 185.991 | 150.877 | 168.879 | 116.283 | 81.939 |
| Other Current Assets
| 98.867 | 61.353 | 99.649 | 30.506 | 43.38 | 33.388 | 48.889 | 36.404 | 47.122 |
| Total Current Assets
| 1,219.475 | 1,442.585 | 1,247.257 | 1,086.827 | 959.637 | 546.273 | 571.224 | 320.727 | 220.146 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 1,381.948 | 1,263.222 | 802.618 | 529.358 | 416.788 | 415.945 | 426.824 | 383.089 | 202.39 |
| Goodwill
| 12.108 | 12.108 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 272.948 | 255.456 | 156.661 | 135.616 | 128.953 | 82.675 | 92.121 | 102.593 | 110.349 |
| Goodwill and Intangible Assets
| 285.057 | 257.364 | 156.661 | 135.616 | 128.953 | 82.675 | 92.121 | 102.593 | 110.349 |
| Long Term Investments
| 0 | 20.444 | 20.096 | 0 | 0 | 0.968 | 0 | 0 | 0.514 |
| Tax Assets
| 13.555 | 19.744 | 5.099 | 8.121 | 15.074 | 1.468 | 0.908 | 0.615 | 0.66 |
| Other Non-Current Assets
| 64.511 | 76.933 | 80.326 | 1.008 | 0.707 | 39.278 | 0.903 | 0.184 | 1.887 |
| Total Non-Current Assets
| 1,745.071 | 1,617.964 | 1,064.8 | 674.103 | 561.523 | 540.333 | 520.756 | 486.481 | 315.801 |
| Total Assets
| 2,964.546 | 3,060.549 | 2,312.057 | 1,760.93 | 1,521.16 | 1,086.606 | 1,091.98 | 807.208 | 535.947 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 404.368 | 190.343 | 24.786 | 149.127 | 154.92 | 147.671 | 105.366 | 180.457 | 100.969 |
| Short Term Debt
| 411.322 | 420.616 | 500.951 | 438.982 | 237.977 | 90.826 | 66.303 | 114.879 | 81.9 |
| Tax Payables
| 8.885 | 37.491 | 24.733 | 28.473 | 20.223 | 32.671 | 21.308 | 19.374 | 12.186 |
| Deferred Revenue
| 0 | 0 | 262.179 | 141.128 | 147.828 | 74.033 | 21.308 | 50.587 | 46.524 |
| Other Current Liabilities
| 613.502 | 408.636 | 506.418 | 111.362 | 55.315 | 127.681 | 203.73 | 34.442 | 106.008 |
| Total Current Liabilities
| 1,438.077 | 1,057.085 | 1,056.888 | 793.946 | 544.524 | 398.849 | 396.707 | 349.152 | 301.064 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 591.873 | 739.499 | 178.404 | 4.101 | 52.047 | 16.5 | 30.523 | 69.724 | 104.877 |
| Deferred Revenue Non-Current
| 96.92 | 76.23 | 61.499 | 32.359 | 8.112 | 9.658 | 11.204 | 1.134 | 1.315 |
| Deferred Tax Liabilities Non-Current
| 2.736 | 2.946 | 177.612 | -32.359 | -0 | -0 | -0 | 0 | -104.877 |
| Other Non-Current Liabilities
| 91.657 | 0 | 61.499 | 0 | 0 | 17.663 | 48.938 | 35.82 | 1.315 |
| Total Non-Current Liabilities
| 783.185 | 818.675 | 239.904 | 36.46 | 60.158 | 43.821 | 90.665 | 106.678 | 106.192 |
| Total Liabilities
| 2,221.262 | 1,901.175 | 1,296.792 | 830.406 | 604.682 | 442.671 | 487.372 | 455.83 | 407.256 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 400.109 | 400.109 | 400.109 | 400.109 | 400.109 | 360.009 | 360.009 | 112 | 60 |
| Retained Earnings
| -55.018 | 365.099 | 265.478 | 187.338 | 181.857 | 78.061 | 50.424 | 30.352 | 9.583 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 57.736 | 50.195 | 43.947 | 52.483 | 194.176 | 209.026 | -0 |
| Other Total Stockholders Equity
| 355.463 | 355.178 | 348.301 | 290.565 | 334.119 | 153.384 | 194.176 | 209.026 | 56.383 |
| Total Shareholders Equity
| 700.553 | 1,120.386 | 1,013.888 | 928.206 | 916.478 | 643.936 | 604.608 | 351.378 | 128.691 |
| Total Equity
| 743.284 | 1,159.373 | 1,015.266 | 930.524 | 916.478 | 643.936 | 604.608 | 351.378 | 128.691 |
| Total Liabilities & Shareholders Equity
| 2,964.546 | 3,060.549 | 2,312.057 | 1,760.93 | 1,521.16 | 1,086.606 | 1,091.98 | 807.208 | 535.947 |